A new genetic test will determine a child's illness even before his conception
IVI Valencia Institute’s specialists introduced a new genetic test to determine 552 possible genetic mutations in an unborn baby even before pregnancy.
To date, diseases caused by genetic disruptions occur in one in 300 newborns. With introduction of the new CGT test we may significantly reduce the incidence of disruptions to one in thirty thousand kids.
Every healthy man carries 6 to 15 unrealized genetic glitches. Most of all, the “disease genes” are not dominant. However, they can reveal themselves in subsequent generations. CGT tests are performed on such indicants as probability of cystic fibrosis, spinal muscular atrophy, cystic kidneys etc. CGT tests use blood samples taken from each of future parents with the known PCR technique. On the basis of this test, patients see a picture of all possible gene changes in every of their future children.
The new test has a particular significance in artificial fertilization and in donor selection. In this case, by selecting "compatibility", future moms can almost completely eliminate a number of possible diseases in their future children.